iTeos Therapeutics, Inc.

NasdaqGM:ITOS Stock Report

Market Cap: US$279.6m

iTeos Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:ITOS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Nov 24BuyUS$38,635Matthew GallIndividual5,000US$7.73
14 Nov 24SellUS$17,500,000Boxer Capital Management, LLCCompany2,000,000US$8.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ITOS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders144,7300.379%
Hedge Funds2,325,0006.09%
General Public3,343,3728.75%
VC/PE Firms6,576,98717.2%
Institutions25,804,25267.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 74.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.7%
MPM BioImpact LLC
4,484,728US$32.8m0%4.51%
9.95%
BlackRock, Inc.
3,801,509US$27.8m-2.09%no data
6.09%
BVF Partners L.P.
2,325,000US$17.0m0%0.67%
5.48%
RA Capital Management, L.P.
2,092,259US$15.3m-34.3%0.21%
4.28%
The Vanguard Group, Inc.
1,634,029US$12.0m-1.37%no data
3.75%
Citadel Advisors LLC
1,432,262US$10.5m15.9%0.01%
3.17%
Dimensional Fund Advisors LP
1,210,080US$8.9m15.7%no data
2.92%
JP Morgan Asset Management
1,115,321US$8.2m166%no data
2.48%
Boxer Capital Management, LLC
946,915US$6.9m0%0.63%
2.41%
Jacobs Levy Equity Management Inc
922,134US$6.8m348%0.03%
2.4%
683 Capital Management, LLC
918,117US$6.7m-41.5%0.73%
2.36%
Vestal Point Capital, LP
900,000US$6.6m-12.2%0.4%
2.24%
JPMorgan Chase & Co, Brokerage and Securities Investments
856,966US$6.3m18,800%no data
2.24%
Citigroup Inc.,Banking and Securities Investments
853,781US$6.2m4,130%no data
2.19%
Renaissance Technologies LLC
837,200US$6.1m56.1%0.01%
1.69%
Geode Capital Management, LLC
644,901US$4.7m0.71%no data
1.53%
State Street Global Advisors, Inc.
585,936US$4.3m-50.2%no data
1.36%
Goldman Sachs Group, Investment Banking and Securities Investments
520,209US$3.8m9.31%no data
1.33%
Caption Management, LLC
509,829US$3.7m0%0.18%
1.23%
Acadian Asset Management LLC
470,146US$3.4m2,680%0.01%
1.08%
Millennium Management LLC
411,072US$3.0m1,010%no data
0.72%
Almitas Capital LLC
275,120US$2.0m0%0.39%
0.68%
Northern Trust Global Investments
259,737US$1.9m3.13%no data
0.61%
Susquehanna International Group, LLP, Asset Management Arm
233,876US$1.7m187%no data
0.58%
Tang Capital Management, LLC
221,716US$1.6m-90.8%0.1%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/17 12:02
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iTeos Therapeutics, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael UlzBaird
Swayampakula RamakanthH.C. Wainwright & Co.
Lut Ming ChengJ.P. Morgan